Genenta Science S.p.A (GNTA) Cash & Current Investments (2020 - 2025)

Genenta Science S.p.A has reported Cash & Current Investments for 6 years, with the latest figure at $59.1 million in Q4 2025.

• Quarterly Cash & Current Investments rose 166.69% year-over-year to $59.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $59.1 million (up 166.69% YoY) and the FY2025 annual result came in at $59.1 million, up 166.69% from the prior year.
• Cash & Current Investments advanced to $59.1 million in Q4 2025 per GNTA's latest filing, from $20.0 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $59.1 million in Q4 2025 and troughed at $10.9 million in Q2 2023.
• A 5-year average of $30.0 million and a median of $30.4 million in 2022 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2023 and 2025: Cash & Current Investments tumbled 70.44% in 2023, then soared 166.69% in 2025.
• Over 5 years, Cash & Current Investments stood at $42.6 million in 2021, then dropped by 28.65% to $30.4 million in 2022, then climbed by 19.85% to $36.4 million in 2023, then plunged by 39.17% to $22.2 million in 2024, then jumped by 166.69% to $59.1 million in 2025.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $59.1 million, $20.0 million, and $22.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.